OTCBB:PKTX

Protokinetix Stock News

Healthcare > Biotechnology

Buy PKTX

*Your capital is at risk

$0.0060

-0.0008 (-11.76%)

At Close: Nov 17, 2025

ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions

08:00am, Wednesday, 12'th May 2021

MARIETTA, Ohio--(BUSINESS WIRE)---- $PKTX #AMD--ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by